Wasatch Advisors Inc Exagen Inc. Transaction History

Wasatch Advisors Inc

  • $20.1 Billion
  • Q3 2024

A detailed history of Wasatch Advisors Inc transactions in Exagen Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 490,205 shares of XGN stock, worth $1.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
490,205
Previous 762,259 35.69%
Holding current value
$1.77 Million
Previous $1.39 Million 9.16%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.74 - $3.42 $473,373 - $930,424
-272,054 Reduced 35.69%
490,205 $1.51 Million
Q2 2024

Aug 14, 2024
SELL
$1.36 - $2.05 $33,504 - $50,503
-24,636 Reduced 3.13%
762,259 $1.39 Million
Q1 2024

Apr 18, 2024
SELL
$1.42 - $2.3 $90,046 - $145,849
-63,413 Reduced 7.46%
786,895 $1.25 Million
Q4 2023

Feb 14, 2024
SELL
$1.45 - $2.39 $8,649 - $14,256
-5,965 Reduced 0.7%
850,308 $1.69 Million
Q3 2023

Nov 14, 2023
SELL
$2.24 - $2.93 $323,839 - $423,593
-144,571 Reduced 14.44%
856,273 $2.07 Million
Q2 2023

Aug 07, 2023
BUY
$2.36 - $3.48 $667 - $984
283 Added 0.03%
1,000,844 $2.9 Million
Q4 2022

Feb 14, 2023
SELL
$2.1 - $3.4 $21,611 - $34,989
-10,291 Reduced 1.02%
1,000,561 $2.4 Million
Q3 2022

Nov 14, 2022
SELL
$2.69 - $8.68 $2,940 - $9,487
-1,093 Reduced 0.11%
1,010,852 $2.74 Million
Q2 2022

Aug 12, 2022
SELL
$4.18 - $7.74 $323,394 - $598,820
-77,367 Reduced 7.1%
1,011,945 $5.81 Million
Q1 2022

May 13, 2022
SELL
$7.12 - $11.06 $117,109 - $181,914
-16,448 Reduced 1.49%
1,089,312 $8.75 Million
Q4 2021

Feb 15, 2022
BUY
$8.97 - $14.08 $67,292 - $105,628
7,502 Added 0.68%
1,105,760 $12.9 Million
Q3 2021

Nov 12, 2021
SELL
$10.25 - $15.21 $6.1 Million - $9.06 Million
-595,420 Reduced 35.16%
1,098,258 $14.9 Million
Q2 2021

Aug 12, 2021
BUY
$12.4 - $17.92 $26,920 - $38,904
2,171 Added 0.13%
1,693,678 $25.4 Million
Q1 2021

May 10, 2021
BUY
$13.9 - $22.0 $8.99 Million - $14.2 Million
647,104 Added 61.96%
1,691,507 $29.6 Million
Q4 2020

Feb 12, 2021
BUY
$11.19 - $16.05 $1.13 Million - $1.61 Million
100,572 Added 10.66%
1,044,403 $13.8 Million
Q3 2020

Nov 10, 2020
BUY
$10.56 - $16.69 $3.44 Million - $5.44 Million
325,786 Added 52.71%
943,831 $10.2 Million
Q2 2020

Aug 12, 2020
SELL
$11.0 - $16.7 $818,114 - $1.24 Million
-74,374 Reduced 10.74%
618,045 $7.67 Million
Q1 2020

May 08, 2020
BUY
$12.7 - $25.95 $4.33 Million - $8.85 Million
341,006 Added 97.04%
692,419 $11 Million
Q4 2019

Feb 13, 2020
SELL
$12.61 - $28.48 $244,823 - $552,939
-19,415 Reduced 5.24%
351,413 $8.93 Million
Q3 2019

Nov 14, 2019
BUY
$14.5 - $17.5 $5.38 Million - $6.49 Million
370,828 New
370,828 $5.74 Million

Others Institutions Holding XGN

# of Institutions
38
Shares Held
6.41M
Call Options Held
4.5K
Put Options Held
400
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $58.7M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email